Under the partnership, Hackensack’s office of innovation will work with the company to develop an AI tool that can detect early-stage carcinoma in situ, according to an April 19 press release from Hackensack Meridian Health.
Nitin Yerram, MD, director of urologic oncology at Hackensack University Medical Center, will spearhead the initiative.
The aim is to integrate the tool into existing clinical workflows.
